STOCKHOLM, Sweden, Nov. 28, 2003 (PRIMEZONE) -- The Extraordinary Shareholder's Meeting in Artimplant on November 28, 2003, decided to approve of the Board of Director's decision on November 6, 2003 to increase the capital of the company with at the most SEK 48 million (before cost of issue) by issuing at the most 11 965 509 new B- shares. The subscription price is SEK 4 per share. Existing shareholders have preferential rights to subscribe for the new shares.
The prospectus will be distributed during the week of December 2-5.
The Extraordinary Shareholder's Meeting also decided according the Board of Director's proposal to authorize the Board, before the next Annual General Meeting, to issue at the most 3 600 000 shares at a price of SEK 4 per share.
N.B. This notice is only a translation. The Swedish notice shall at all times have precedence.
For additional information, please contact:
Tord Lendau, CEO,
phone +46 (0)31 746 56 00, +46 (0)708 369 403, tord.lendau@artimplant.se
Ulf Akerblom, VP Corporate Development, phone +46 (0)31 746 56 00, +46 (0)709 675 999, ulf.akerblom@artimplant.se
ARTIMPLANT
Artimplant is a biomaterial company that focuses on orthopedic surgery solutions. The company runs R&D operations for biodegradable implants and develops manufacturing processes for the implants. Its goal is to enable active lives. Artimplant's biomaterial is based on a new technology that's opening new markets within orthopedic surgery and closely related areas that have extensive med-tech needs.
Artimplant developed and patented several different degradable ligament implants that are now in clinical trials. The company's business concept is to license products and technologies to global partners.
The Artimplant share is listed on the Stockholm stock exchange's O list.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://www.waymaker.net/bitonline/2003/11/28/20031128BIT00540/wkr0001.doc
http://www.waymaker.net/bitonline/2003/11/28/20031128BIT00540/wkr0002.pdf